首页 > 最新文献

Jurimetrics最新文献

英文 中文
Genetic privacy and the law: an end to genetics exceptionalism. 基因隐私与法律:基因例外主义的终结。
Pub Date : 1999-01-01
L O Gostin, J G Hodge

While the proliferation of human genetic information promises to achieve many public benefits, the acquisition, use, retention, and disclosure of genetic data threatens individual liberties. States (and to a lesser degree, the federal government) have responded to the anticipated and actual threats of privacy invasion and discrimination by enacting several types of genetic-specific legislation. These laws emphasize the differences between genetic information and other health information. By articulating these differences, governments afford genetic data an "exceptional" status. The authors argue that genetic exceptionalism is flawed for two reasons: (1) strict protections of autonomy, privacy, and equal treatment of persons with genetic conditions threaten the accomplishment of public goods; and (2) there is no clear demarcation separating genetic data from other health data; other health data deserve protections in a national health information infrastructure. The authors present ideas for individual privacy protections that balance the societal need for genetic information and the claims for privacy by individuals and families.

虽然人类基因信息的扩散有望实现许多公共利益,但基因数据的获取、使用、保留和披露威胁着个人自由。各州(在较小程度上,联邦政府)已经通过制定几种特定基因的立法来应对预期和实际的隐私侵犯和歧视威胁。这些法律强调了遗传信息和其他健康信息之间的区别。通过阐明这些差异,政府赋予基因数据“特殊”地位。作者认为,基因例外论存在缺陷,原因有二:(1)严格保护自主、隐私和平等对待遗传疾病患者会威胁到公共产品的实现;(2)遗传数据与其他健康数据没有明确的界限;其他卫生数据应在国家卫生信息基础设施中得到保护。作者提出了个人隐私保护的想法,以平衡社会对遗传信息的需求和个人和家庭对隐私的要求。
{"title":"Genetic privacy and the law: an end to genetics exceptionalism.","authors":"L O Gostin,&nbsp;J G Hodge","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>While the proliferation of human genetic information promises to achieve many public benefits, the acquisition, use, retention, and disclosure of genetic data threatens individual liberties. States (and to a lesser degree, the federal government) have responded to the anticipated and actual threats of privacy invasion and discrimination by enacting several types of genetic-specific legislation. These laws emphasize the differences between genetic information and other health information. By articulating these differences, governments afford genetic data an \"exceptional\" status. The authors argue that genetic exceptionalism is flawed for two reasons: (1) strict protections of autonomy, privacy, and equal treatment of persons with genetic conditions threaten the accomplishment of public goods; and (2) there is no clear demarcation separating genetic data from other health data; other health data deserve protections in a national health information infrastructure. The authors present ideas for individual privacy protections that balance the societal need for genetic information and the claims for privacy by individuals and families.</p>","PeriodicalId":81748,"journal":{"name":"Jurimetrics","volume":" ","pages":"21-58"},"PeriodicalIF":0.0,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22141993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethical genetic research on human subjects. 人类受试者的伦理基因研究。
Pub Date : 1999-01-01
J Harris

Since the Nuremberg trials and the Nazi doctors trial following World War II, international ethics protocols have emerged designed to protect human subjects from the atrocities of medical experimentation that were literally routine under the Nazis. Some of the apparent "lessons" from the Nazi period have been encapsulated in the Declaration of Helsinki, perhaps the leading medical ethics protocol. This paper argues that these protocols have not been notably conducive to human welfare or to the protection of human rights in the field of human genetics research. The paper proposes new protocols and a new approach to the ethics of research on human subjects.

自二战后纽伦堡审判和纳粹医生审判以来,国际道德规范应运而生,旨在保护人类受试者免受纳粹统治下习以为常的医学实验暴行的伤害。从纳粹时期吸取的一些明显的“教训”已被浓缩在《赫尔辛基宣言》(Declaration of Helsinki)中,这或许是最重要的医学伦理协议。本文认为,在人类遗传学研究领域,这些协议并没有显著地有利于人类福利或保护人权。本文提出了人类研究伦理的新协议和新途径。
{"title":"Ethical genetic research on human subjects.","authors":"J Harris","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Since the Nuremberg trials and the Nazi doctors trial following World War II, international ethics protocols have emerged designed to protect human subjects from the atrocities of medical experimentation that were literally routine under the Nazis. Some of the apparent \"lessons\" from the Nazi period have been encapsulated in the Declaration of Helsinki, perhaps the leading medical ethics protocol. This paper argues that these protocols have not been notably conducive to human welfare or to the protection of human rights in the field of human genetics research. The paper proposes new protocols and a new approach to the ethics of research on human subjects.</p>","PeriodicalId":81748,"journal":{"name":"Jurimetrics","volume":" ","pages":"77-91"},"PeriodicalIF":0.0,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25686413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding prohibitions against genetic discrimination in insurance. 了解保险中对基因歧视的禁令。
Pub Date : 1999-01-01
K S Abraham

The justification for laws prohibiting genetic discrimination in health insurance is not at all clear. Neither privacy protection, the distinctive features of health insurance, nor the distinction between presymptomatic genetic tendencies and actually manifested disease provide a justification, although certain practical considerations may justify these laws.

在健康保险中禁止基因歧视的法律的正当性一点也不清楚。隐私保护、健康保险的特点、症状前遗传倾向和实际表现的疾病之间的区别都不能成为理由,尽管某些实际考虑可以证明这些法律是合理的。
{"title":"Understanding prohibitions against genetic discrimination in insurance.","authors":"K S Abraham","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The justification for laws prohibiting genetic discrimination in health insurance is not at all clear. Neither privacy protection, the distinctive features of health insurance, nor the distinction between presymptomatic genetic tendencies and actually manifested disease provide a justification, although certain practical considerations may justify these laws.</p>","PeriodicalId":81748,"journal":{"name":"Jurimetrics","volume":" ","pages":"123-8"},"PeriodicalIF":0.0,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25154885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Who are the parents of biotechnological children? 谁是生物技术孩子的父母?
Pub Date : 1994-01-01 DOI: 10.31228/osf.io/98wys
L. Palmer
L'A. souleve la question du statut legislatif et ethique du recours a la biotechnologie de la reproduction (fecondation in vitro, implantation d'embryon, congelation du sperme...) Il s'agit de savoir si l'on peut beneficier de cette technologie nouvelle en minimisant les risques d'abus
那样。提出使用生殖生物技术(体外受精、胚胎植入、精子冷冻等)的立法和伦理地位问题。问题是,是否有可能从这项新技术中获益,将滥用风险降至最低。
{"title":"Who are the parents of biotechnological children?","authors":"L. Palmer","doi":"10.31228/osf.io/98wys","DOIUrl":"https://doi.org/10.31228/osf.io/98wys","url":null,"abstract":"L'A. souleve la question du statut legislatif et ethique du recours a la biotechnologie de la reproduction (fecondation in vitro, implantation d'embryon, congelation du sperme...) Il s'agit de savoir si l'on peut beneficier de cette technologie nouvelle en minimisant les risques d'abus","PeriodicalId":81748,"journal":{"name":"Jurimetrics","volume":"93 1","pages":"17-29"},"PeriodicalIF":0.0,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88404683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Deception in scientific research. 科学研究中的欺骗。
Pub Date : 1988-01-01 DOI: 10.4324/9781315244426-9
P. Woolf
Truth in science depends on the researcher's unbiased application of proven inves? tigative techniques to appropriate experiments. Unfortunately, reports of serious devia? tions from this ideal are becoming increasingly common. The media, the general public, and the scientific community have reacted with shock, disapproval, confusion, and loss of confidence in experimental results. Consequently, congressional committees have taken renewed interest in oversight of research. This article describes recent incidents of alleged misconduct in research and their detection, disclosure, and disciplinary actions taken against the researchers apparently at fault. It argues that stricter, more vigilant procedures to prevent fraudulent research from ever being published are needed. Corrective measures when fraud is discovered after publication must include due process in all investigations and careful retractions in the scientific journals. The article draws attention to several differences in the way that scientists and lawyers assemble and evaluate evidence. No statute of limitations protects the perpetrator of scientific misconduct. The maintenance of integrity in research is therefore a permanent professional responsibility. ?Patricia Woolf is the former co-director of the Ethics and Science Project, Sociology Depart? ment, at Princeton University. She will be teaching at Princeton's Woodrow Wilson School in the Spring of 1989. This article is part of the interim report of the Project on Scientific Fraud and Misconduct of the American Association for the Advancement of Science?American Bar Associ? ation National Conference of Lawyers and Scientists. Since this report was initially prepared, a new dispute involving possible error in a published paper on transgenic research has developed into something of a cause celeebre leading even to congressional hearings. See Culliton, A Bitter Battle Over Error, 240 Sei. 1720(1988); Culliton,^! Bitter Battle Over Error (II), 241 Sei. 18 (1988); Scientific Fraud and Misconduct: Hearings Be? fore the Subcomm. on Human Resources and Individual Rights of the House of Representatives Comm. on Government Operations, 100th Cong., 2nd Sess. (Apr. 11, 1988); NIH Biomedical Grant Programs: Hearings Before the Subcomm. on Oversight and Investigations of the House of Representatives Comm. on Energy and Commerce, 100th Cong., 2nd Sess. (Apr. 12, 1988).
科学中的真理取决于研究者对已证实的实验的公正应用。阴性技术,以适当的实验。不幸的是,有报道称严重的devia?与这种理想相悖的行为正变得越来越普遍。媒体、公众和科学界的反应是震惊、不赞成、困惑和对实验结果失去信心。因此,国会委员会重新对研究监督产生了兴趣。这篇文章描述了最近在研究中被指控的不端行为,以及对这些不端行为的发现、披露和对明显有过错的研究人员采取的纪律处分。它认为,需要更严格、更警惕的程序来防止欺诈性研究的发表。在发表后发现欺诈时,纠正措施必须包括所有调查的正当程序和科学期刊上的谨慎撤回。这篇文章让人们注意到科学家和律师在收集和评估证据的方式上的几个差异。没有法定时效保护科学不端行为的肇事者。因此,维护科研诚信是一项永久的职业责任。帕特里夏·伍尔夫(Patricia Woolf)是社会学系伦理与科学项目的前联合主任。ment,普林斯顿大学教授。本文是美国科学促进会科学欺诈和不端行为项目中期报告的一部分。美国律师协会?全国律师和科学家会议。自从这份报告最初准备好以来,一篇关于转基因研究的已发表论文中可能存在的错误引发了一场新的争议,这已经发展成为一项声名鹊起的事业,甚至导致了国会听证会。参见Culliton, A Bitter Battle of Error, 240 Sei. 1720(1988);Culliton, ^ !《错误的苦战》(下),241卷18期(1988);科学欺诈和不端行为:听证会?在Subcomm之前。关于人力资源和个人权利的众议院委员会政府运作,第100届会议,第二次会议。(1988年4月11日);美国国立卫生研究院生物医学资助计划:小组委员会之前的听证会。关于众议院能源和商业委员会的监督和调查,第100届国会第二次会议。(1988年4月12日)。
{"title":"Deception in scientific research.","authors":"P. Woolf","doi":"10.4324/9781315244426-9","DOIUrl":"https://doi.org/10.4324/9781315244426-9","url":null,"abstract":"Truth in science depends on the researcher's unbiased application of proven inves? tigative techniques to appropriate experiments. Unfortunately, reports of serious devia? tions from this ideal are becoming increasingly common. The media, the general public, and the scientific community have reacted with shock, disapproval, confusion, and loss of confidence in experimental results. Consequently, congressional committees have taken renewed interest in oversight of research. This article describes recent incidents of alleged misconduct in research and their detection, disclosure, and disciplinary actions taken against the researchers apparently at fault. It argues that stricter, more vigilant procedures to prevent fraudulent research from ever being published are needed. Corrective measures when fraud is discovered after publication must include due process in all investigations and careful retractions in the scientific journals. The article draws attention to several differences in the way that scientists and lawyers assemble and evaluate evidence. No statute of limitations protects the perpetrator of scientific misconduct. The maintenance of integrity in research is therefore a permanent professional responsibility. ?Patricia Woolf is the former co-director of the Ethics and Science Project, Sociology Depart? ment, at Princeton University. She will be teaching at Princeton's Woodrow Wilson School in the Spring of 1989. This article is part of the interim report of the Project on Scientific Fraud and Misconduct of the American Association for the Advancement of Science?American Bar Associ? ation National Conference of Lawyers and Scientists. Since this report was initially prepared, a new dispute involving possible error in a published paper on transgenic research has developed into something of a cause celeebre leading even to congressional hearings. See Culliton, A Bitter Battle Over Error, 240 Sei. 1720(1988); Culliton,^! Bitter Battle Over Error (II), 241 Sei. 18 (1988); Scientific Fraud and Misconduct: Hearings Be? fore the Subcomm. on Human Resources and Individual Rights of the House of Representatives Comm. on Government Operations, 100th Cong., 2nd Sess. (Apr. 11, 1988); NIH Biomedical Grant Programs: Hearings Before the Subcomm. on Oversight and Investigations of the House of Representatives Comm. on Energy and Commerce, 100th Cong., 2nd Sess. (Apr. 12, 1988).","PeriodicalId":81748,"journal":{"name":"Jurimetrics","volume":"48 1","pages":"67-95"},"PeriodicalIF":0.0,"publicationDate":"1988-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73791436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
期刊
Jurimetrics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1